State AI regulatory sandbox features

The massive infrastructure push has taken on greater urgency since the US and EU began excluding Chinese scientists from accessing some of its most sensitive data

Organizations face growing pressure to adopt artificial intelligence, but often lack practical guidance on how to do so effectively. This report bridges the gap between high-level principles and real-...

CSET researchers share their early analysis of the White House's AI Policy Framework and what the prospects are for near-term legislative action on AI.

The barriers to bioattacks are hard to identify — and it's even harder to know whether AI is reducing them

The administration’s attempt to suppress state AI regulation risks legal backlash, bipartisan resistance, and public distrust, undermining the innovation it seeks to advance.  The Trump administration...

The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering techniques, and globalized scientific research drive progress in biotechnology.

This report presents an analytic approach to help U.S. policymakers deconstruct artificial intelligence governance proposals by identifying their underlying assumptions, which are the foundational ele...

The rising death toll for a preventable disease reveals just how ill-prepared the country is to handle a malicious bioweapon.

Moving forward with the Biden administration’s guidance could deliver lower drug prices and allow more Americans to reap the benefits of public science. In late 2023, the federal government published ...

The companies that sell synthesized DNA to scientists need to screen their customers, lest dangerous sequences for pathogens or toxins fall into the wrong hands.

The companies that sell synthesized DNA to scientists need to screen their customers, lest dangerous sequences for pathogens or toxins fall into the wrong hands.

In response to the Office of Science and Technology Policy's request for input on an AI Action Plan, CSET provides key recommendations for advancing AI research, ensuring U.S. competitiveness, and max...

Artificial intelligence (AI) tools pose exciting possibilities to advance scientific, biomedical, and public health research. At the same time, these tools have raised concerns about their potential t...

Dr. Steph Batalis and Vikram Venkatram offered the following comment in response to the National Institute of Standards and Technology's request for information on safety considerations for chemical a...